Publication | Open Access

Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial

Respiratory Distress Syndrome (Pulmonary Critical Care)Covid-19 PandemicIntravenous ImmunoglobulinsRespiratory InfectionInfectious Respiratory DiseaseRespiratory Distress Syndrome (Neonatal Medicine)Acute MedicineMedicineCovid-19